Candidate polio vaccines are safe and immunogenic
5 June 2019
The Lancet reports on a unique polio studio by the University of Antwerp
Findings from the first-in-human study of a new polio vaccine – novel oral polio vaccine, or nOPV – reported in The Lancet this week are promising. If subsequent studies are successful, such a vaccine has the potential to supplement current eradication efforts and sustain eradication of all types of polioviruses for the long-term.